Skip to main content
. 2017 Apr 12;2(1):e000101. doi: 10.1136/esmoopen-2016-000101

Figure 1.

Figure 1

Case 2—volumetric MRI tumour measurements of perihepatic and pelvic mesothelioma demonstrating a 39% reduction in tumour volume after 10 months treatment with apitolisib.